Open-label Safety and Tolerability Study of Dabigatran Etexilate Mesilate Given for 3 Days at the End of Standard Anticoagulant Therapy in Children Aged 12 Years to Less Than 18 Years
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00003559/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
To investigate the safety and tolerability of dabigatran etexilate capsules in a small group of eight adolescent patients.
提供机构：
Vivli
创建时间：
2019-04-12
